Showing results (991-1000 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|September 4, 2024
Carotid ultrasound to identify head and neck cancer survivors with high cardiovascular risk after radiation therapy: rationale and design of a prospective, cross-sectional pilot studyRyan T Hughes, Anna C Snavely, Emily V Dressler, et al.
Future Oncology (London, England)|August 19, 2024
Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USALiya Wang, Mukul Singhal, Adriana Valderrama, et al.
Future Oncology (London, England)|November 25, 2024
Homologous recombination deficiency in pancreatic neuroendocrine tumorsCamilla Bardasi, Elena Tenedini, Lia Bonamici, et al.
Future Oncology (London, England)|November 27, 2024
Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancerJordyn P Higgins, Jennifer W Carlisle, Nader H Moniri, et al.
Future Oncology (London, England)|November 20, 2024
Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysisJialin Zhang, Jingyang Su, Cui Ni, et al.
Future Oncology (London, England)|November 19, 2024
Genetic variants in mitochondrial sirtuins associated with brain tumor risk: a case-control studyMaria Fazal Ul Haq, Muhammad Zahid Hussain, Muhammad Shahbaz Haris, et al.
Future Oncology (London, England)|November 18, 2024
Physician preferences of biomarker testing strategies in newly diagnosed stage IV non-small cell lung cancer patientsAnne Shah, Jon Apple, Gabriela Burgos, et al.
Future Oncology (London, England)|November 15, 2024
Locally advanced/metastatic non-small-cell lung cancer in Lebanon: focus on ALK tyrosine kinase inhibitorsArafat Tfayli, Hady Ghanem, Fadi Nasr, et al.
Future Oncology (London, England)|August 12, 2024
Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysisAlain Chebly
Future Oncology (London, England)|July 18, 2024
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancerFabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg, et al.
Pageof 452